The enhanced membrane interaction and perturbation of a cell penetrating peptide in the presence of anionic lipids: Toward an understanding of its selectivity for cancer cells

Biochimica et Biophysica Acta - Biomembranes

Volumn 1828, Issue 6, 2013, Pages 1457-1470

  Jobin, Marie Lise ^a   Bonnafous, Pierre ^a   Temsamani, Hamza ^a   Dole, François ^b   Grélard, Axelle ^a   Dufourc, Erick J ^a   Alves, Isabel D ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b CENTRE DE RECHERCHE PAUL PASCAL   (France)

Author keywords

Anticancer activity; Cell penetrating peptide; Lipid model system; Peptide lipid interaction

Indexed keywords

AMPHOLYTE; CELL PENETRATING PEPTIDE; LIPOSOME; RW16; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BIOLOGICAL MODEL; CONTROLLED STUDY; DRUG BINDING; DRUG EFFECT; DRUG MECHANISM; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; MEMBRANE BINDING; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION; TRANSMISSION ELECTRON MICROSCOPY; TURBIDITY;

ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CELL-PENETRATING PEPTIDES; ESCHERICHIA COLI; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; KLEBSIELLA PNEUMONIAE; LIPOSOMES; MEMBRANE LIPIDS; MICROBIAL SENSITIVITY TESTS; PROTEIN CONFORMATION; STAPHYLOCOCCUS AUREUS; TRYPTOPHAN;

EID: 84874933223     PISSN: 00052736     EISSN: 18792642     Source Type: Journal    
DOI: 10.1016/j.bbamem.2013.02.008     Document Type: Article

References (68)

1. M. Zorko, and U. Langel Cell-penetrating peptides: mechanism and kinetics of cargo delivery Adv. Drug Deliv. Rev. 57 2005 529 545
2. G.P. Dietz, and M. Bahr Delivery of bioactive molecules into the cell: the Trojan horse approach Mol. Cell. Neurosci. 27 2004 85 131
3. C. Foerg, and H.P. Merkle On the biomedical promise of cell penetrating peptides: limits versus prospects J. Pharm. Sci. 97 2008 144 162
4. E. Gros, S. Deshayes, M.C. Morris, G. Aldrian-Herrada, J. Depollier, F. Heitz, and G. Divita A non-covalent peptide-based strategy for protein and peptide nucleic acid transduction Biochim. Biophys. Acta 1758 2006 384 393
5. S. Moschos, A. Williams, and M. Lindsay In vivo applications of cell-penetrating peptide U. Langel, Cell-Penetrating Peptides 2007 CRC Press Boca Raton 423 438
6. L.N. Patel, J.L. Zaro, and W.C. Shen Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives Pharm. Res. 24 2007 1977 1992
7. A.T. Jones, and E.J. Sayers Cell entry of cell penetrating peptides: tales of tails wagging dogs J. Control. Release 161 2012 582 591
8. H.A. Rydberg, M. Matson, H.L. Amand, E.K. Esbjorner, and B. Norden Effects of tryptophan content and backbone spacing on the uptake efficiency of cell-penetrating peptides Biochemistry 51 27 2012 5531 5539
9. D. Derossi, G. Chassaing, and A. Prochiantz Trojan peptides: the penetratin system for intracellular delivery Trends Cell Biol. 8 1998 84 87
10. D. Delaroche, F.X. Cantrelle, F. Subra, C. Van Heijenoort, E. Guittet, C.Y. Jiao, L. Blanchoin, G. Chassaing, S. Lavielle, C. Auclair, and S. Sagan Cell-penetrating peptides with intracellular actin-remodeling activity in malignant fibroblasts J. Biol. Chem. 285 2010 7712 7721
11. A. Lamaziere, F. Burlina, C. Wolf, G. Chassaing, G. Trugnan, and J. Ayala-Sanmartin Non-metabolic membrane tubulation and permeability induced by bioactive peptides PLoS One 2 2007 e201
12. S. Richter, V. Bouvet, M. Wuest, R. Bergmann, J. Steinbach, J. Pietzsch, I. Neundorf, and F. Wuest (18)F-Labeled phosphopeptide-cell-penetrating peptide dimers with enhanced cell uptake properties in human cancer cells Nucl. Med. Biol. 39 8 2012 1202 1212
13. I. Nakase, Y. Konishi, M. Ueda, H. Saji, and S. Futaki Accumulation of arginine-rich cell-penetrating peptides in tumors and the potential for anticancer drug delivery in vivo J. Control. Release 159 2012 181 188
14. E. Kondo, K. Saito, Y. Tashiro, K. Kamide, S. Uno, T. Furuya, M. Mashita, K. Nakajima, T. Tsumuraya, N. Kobayashi, M. Nishibori, M. Tanimoto, and M. Matsushita Tumour lineage-homing cell-penetrating peptides as anticancer molecular delivery systems Nat. Commun. 3 2012 951
15. J.H. Lee, H. Park, H. Chung, S. Choi, Y. Kim, H. Yoo, T.Y. Kim, H.J. Hann, I. Seong, J. Kim, K.G. Kang, I.O. Han, and E.S. Oh Syndecan-2 regulates the migratory potential of melanoma cells J. Biol. Chem. 284 2009 27167 27175
16. K. Matsuda, H. Maruyama, F. Guo, J. Kleeff, J. Itakura, Y. Matsumoto, A.D. Lander, and M. Korc Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells Cancer Res. 61 2001 5562 5569
17. R.D. Sanderson Heparan sulfate proteoglycans in invasion and metastasis Semin. Cell Dev. Biol. 12 2001 89 98
18. I. Vlodavsky, O. Goldshmidt, E. Zcharia, R. Atzmon, Z. Rangini-Guatta, M. Elkin, T. Peretz, and Y. Friedmann Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development Semin. Cancer Biol. 12 2002 121 129
19. S.J. Martin, C.P. Reutelingsperger, A.J. McGahon, J.A. Rader, R.C. van Schie, D.M. LaFace, and D.R. Green Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl J. Exp. Med. 182 1995 1545 1556
20. S.T. Henriques, M.N. Melo, and M.A. Castanho Cell-penetrating peptides and antimicrobial peptides: how different are they? Biochem. J. 399 2006 1 7
21. I.D. Alves, N. Goasdoue, I. Correia, S. Aubry, C. Galanth, S. Sagan, S. Lavielle, and G. Chassaing Membrane interaction and perturbation mechanisms induced by two cationic cell penetrating peptides with distinct charge distribution Biochim. Biophys. Acta 1780 2008 948 959
22. J.S. Bahnsen, H. Franzyk, A. Sandberg-Schaal, and H.M. Nielsen Antimicrobial and cell-penetrating properties of penetratin analogs: effect of sequence and secondary structure Biochim. Biophys. Acta 1828 2013 223 232
23. C. Palm, S. Netzereab, and M. Hallbrink Quantitatively determined uptake of cell-penetrating peptides in non-mammalian cells with an evaluation of degradation and antimicrobial effects Peptides 27 2006 1710 1716
24. K. Splith, and I. Neundorf Antimicrobial peptides with cell-penetrating peptide properties and vice versa Eur. Biophys. J. 40 2011 387 397
25. P. Wadhwani, R.F. Epand, N. Heidenreich, J. Burck, A.S. Ulrich, and R.M. Epand Membrane-active peptides and the clustering of anionic lipids Biophys. J. 103 2012 265 274
26. N. Papo, and Y. Shai New lytic peptides based on the d,l-amphipathic helix motif preferentially kill tumor cells compared to normal cells Biochemistry 42 2003 9346 9354
27. S.A. Johnstone, K. Gelmon, L.D. Mayer, R.E. Hancock, and M.B. Bally In vitro characterization of the anticancer activity of membrane-active cationic peptides. I. Peptide-mediated cytotoxicity and peptide-enhanced cytotoxic activity of doxorubicin against wild-type and p-glycoprotein over-expressing tumor cell lines Anticancer Drug Des. 15 2000 151 160
28. F.S. Kao, Y.R. Pan, R.Q. Hsu, and H.M. Chen Efficacy verification and microscopic observations of an anticancer peptide, CB1a, on single lung cancer cell Biochim. Biophys. Acta 1818 2012 2927 2935
29. M. Amiche, A.A. Seon, H. Wroblewski, and P. Nicolas Isolation of dermatoxin from frog skin, an antibacterial peptide encoded by a novel member of the dermaseptin genes family Eur. J. Biochem. 267 2000 4583 4592
30. P. Bonnafous, and T. Stegmann Membrane perturbation and fusion pore formation in influenza hemagglutinin-mediated membrane fusion. A new model for fusion J. Biol. Chem. 275 2000 6160 6166
31. G. Rouser, S. Fkeischer, and A. Yamamoto Two dimensional then layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots Lipids 5 1970 494 496
32. T. Pott, and E.J. Dufourc Action of melittin on the DPPC-cholesterol liquid-ordered phase: a solid state 2H- and 31P-NMR study Biophys. J. 68 1995 965 977
33. P. Mueller, D.O. Rudin, H.T. Tien, and W.C. Wescott Reconstitution of cell membrane structure in vitro and its transformation into an excitable system Nature 194 1962 979 980
34. Z. Salamon, G. Tollin, I. Alves, and V. Hruby Chapter 6. Plasmon resonance methods in membrane protein biology applications to GPCR signaling Methods Enzymol. 461 2009 123 146
35. I.D. Alves, S.M. Cowell, Z. Salamon, S. Devanathan, G. Tollin, and V.J. Hruby Different structural states of the proteolipid membrane are produced by ligand binding to the human delta-opioid receptor as shown by plasmon-waveguide resonance spectroscopy Mol. Pharmacol. 65 2004 1248 1257
36. Z. Salamon, and G. Tollin Graphical analysis of mass and anisotropy changes observed by plasmon-waveguide resonance spectroscopy can provide useful insights into membrane protein function Biophys. J. 86 2004 2508 2516
37. I.D. Alves, I. Correia, C.Y. Jiao, E. Sachon, S. Sagan, S. Lavielle, G. Tollin, and G. Chassaing The interaction of cell-penetrating peptides with lipid model systems and subsequent lipid reorganization: thermodynamic and structural characterization J. Pept. Sci. 15 2009 200 209
38. S. Devanathan, Z. Salamon, G. Tollin, J. Fitch, T.E. Meyer, and M.A. Cusanovich Binding of oxidized and reduced cytochrome c2 to photosynthetic reaction centers: plasmon-waveguide resonance spectroscopy Biochemistry 43 2004 16405 16415
39. P. Lecorche, A. Walrant, F. Burlina, L. Dutot, S. Sagan, J.M. Mallet, B. Desbat, G. Chassaing, I.D. Alves, and S. Lavielle Cellular uptake and biophysical properties of galactose and/or tryptophan containing cell-penetrating peptides Biochim. Biophys. Acta 1818 2012 448 457
40. H. Binder, and G. Lindblom Charge-dependent translocation of the Trojan peptide penetratin across lipid membranes Biophys. J. 85 2003 982 995
41. A. Ziegler, and J. Seelig Contributions of glycosaminoglycan binding and clustering to the biological uptake of the nonamphipathic cell-penetrating peptide WR9 Biochemistry 50 2011 4650 4664
42. A. Ziegler, and J. Seelig Binding and clustering of glycosaminoglycans: a common property of mono- and multivalent cell-penetrating compounds Biophys. J. 94 2008 2142 2149
43. J.M. Seddon Structure of the inverted hexagonal (HII) phase, and non-lamellar phase transitions of lipids Biochim. Biophys. Acta 1031 1990 1 69
44. D.I. Chan, E.J. Prenner, and H.J. Vogel Tryptophan- and arginine-rich antimicrobial peptides: structures and mechanisms of action Biochim. Biophys. Acta 1758 2006 1184 1202
45. D. Lichtenberg, E. Freire, C.F. Schmidt, Y. Barenholz, P.L. Felgner, and T.E. Thompson Effect of surface curvature on stability, thermodynamic behavior, and osmotic activity of dipalmitoylphosphatidylcholine single lamellar vesicles Biochemistry 20 1981 3462 3467
46. S. Thennarasu, A. Tan, R. Penumatchu, C.E. Shelburne, D.L. Heyl, and A. Ramamoorthy Antimicrobial and membrane disrupting activities of a peptide derived from the human cathelicidin antimicrobial peptide LL37 Biophys. J. 98 2010 248 257
47. Y.P. Zhang, R.N. Lewis, R.S. Hodges, and R.N. McElhaney Interaction of a peptide model of a hydrophobic transmembrane alpha-helical segment of a membrane protein with phosphatidylcholine bilayers: differential scanning calorimetric and FTIR spectroscopic studies Biochemistry 31 1992 11579 11588
48. R.F. Epand, M.A. Schmitt, S.H. Gellman, and R.M. Epand Role of membrane lipids in the mechanism of bacterial species selective toxicity by two alpha/beta-antimicrobial peptides Biochim. Biophys. Acta 1758 2006 1343 1350
49. R.F. Epand, G. Wang, B. Berno, and R.M. Epand Lipid segregation explains selective toxicity of a series of fragments derived from the human cathelicidin LL-37 Antimicrob. Agents Chemother. 53 2009 3705 3714
50. R.M. Epand, R.F. Epand, C.J. Arnusch, B. Papahadjopoulos-Sternberg, G. Wang, and Y. Shai Lipid clustering by three homologous arginine-rich antimicrobial peptides is insensitive to amino acid arrangement and induced secondary structure Biochim. Biophys. Acta 1798 2010 1272 1280
51. P. Joanne, C. Galanth, N. Goasdoue, P. Nicolas, S. Sagan, S. Lavielle, G. Chassaing, C. El Amri, and I.D. Alves Lipid reorganization induced by membrane-active peptides probed using differential scanning calorimetry Biochim. Biophys. Acta 1788 2009 1772 1781
52. B.J. Potter, T.A. McHugh, and O. Beloqui Iron uptake from transferrin and asialotransferrin by hepatocytes from chronically alcohol-fed rats Alcohol. Clin. Exp. Res. 16 1992 810 815
53. H. Leontiadou, A.E. Mark, and S.J. Marrink Antimicrobial peptides in action J. Am. Chem. Soc. 128 2006 12156 12161
54. C.F. Lopez, S.O. Nielsen, G. Srinivas, W.F. Degrado, and M.L. Klein Probing membrane insertion activity of antimicrobial polymers via coarse-grain molecular dynamics J. Chem. Theory Comput. 2 2006 649 655
55. L.E. Yandek, A. Pokorny, A. Floren, K. Knoelke, U. Langel, and P.F. Almeida Mechanism of the cell-penetrating peptide transportan 10 permeation of lipid bilayers Biophys. J. 92 2007 2434 2444
56. D.K. Hincha, and J.H. Crowe The lytic activity of the bee venom peptide melittin is strongly reduced by the presence of negatively charged phospholipids or chloroplast galactolipids in the membranes of phosphatidylcholine large unilamellar vesicles Biochim. Biophys. Acta 1284 1996 162 170
57. Z. Salamon, and G. Tollin Optical anisotropy in lipid bilayer membranes: coupled plasmon-waveguide resonance measurements of molecular orientation, polarizability, and shape Biophys. J. 80 2001 1557 1567
58. W.T. Heller, A.J. Waring, R.I. Lehrer, T.A. Harroun, T.M. Weiss, L. Yang, and H.W. Huang Membrane thinning effect of the beta-sheet antimicrobial protegrin Biochemistry 39 2000 139 145
59. A. Mecke, D.K. Lee, A. Ramamoorthy, B.G. Orr, and M.M. Banaszak Holl Membrane thinning due to antimicrobial peptide binding: an atomic force microscopy study of MSI-78 in lipid bilayers Biophys. J. 89 2005 4043 4050
60. P. Garidel, and A. Blume Interaction of alkaline earth cations with the negatively charged phospholipid 1,2-dimyristoyl-sn-glycero-3-phosphoglycerol: a differential scanning and isothermal titration calorimetric study Langmuir 15 1999 9
61. E. Barany-Wallje, S. Keller, S. Serowy, S. Geibel, P. Pohl, M. Bienert, and M. Dathe A critical reassessment of penetratin translocation across lipid membranes Biophys. J. 89 2005 2513 2521
62. A. Walrant, A. Vogel, I. Correia, O. Lequin, B.E. Olausson, B. Desbat, S. Sagan, and I.D. Alves Membrane interactions of two arginine-rich peptides with different cell internalization capacities Biochim. Biophys. Acta 1818 2012 1755 1763
63. M. Magzoub, L.E. Eriksson, and A. Graslund Conformational states of the cell-penetrating peptide penetratin when interacting with phospholipid vesicles: effects of surface charge and peptide concentration Biochim. Biophys. Acta 1563 2002 53 63
64. R.W. Woody Contributions of tryptophan side chains to the far-ultraviolet circular dichroism of proteins Eur. Biophys. J. 23 1994 253 262
65. A.S. Ladokhin, M.E. Selsted, and S.H. White CD spectra of indolicidin antimicrobial peptides suggest turns, not polyproline helix Biochemistry 38 1999 12313 12319
66. V.V. Andrushchenko, H.J. Vogel, and E.J. Prenner Solvent-dependent structure of two tryptophan-rich antimicrobial peptides and their analogs studied by FTIR and CD spectroscopy Biochim. Biophys. Acta 1758 2006 1596 1608
67. A. Lamaziere, C. Wolf, O. Lambert, G. Chassaing, G. Trugnan, and J. Ayala-Sanmartin The homeodomain derived peptide penetratin induces curvature of fluid membrane domains PLoS One 3 2008 e1938
68. A. Lamaziere, O. Maniti, C. Wolf, O. Lambert, G. Chassaing, G. Trugnan, and J. Ayala-Sanmartin Lipid domain separation, bilayer thickening and pearling induced by the cell penetrating peptide penetratin Biochim. Biophys. Acta 1798 2010 2223 2230